| AFP | Alpha(α) Feto-Protein [HP 1826, 1858, 1859, 2265] ; Oncofetal Antigens &nbs... |
|---|---|
| CHRONIC | chronic disease, rheumatoid arthritis, neoplasms, infections, cryoglobulinemia [conditions in which ... |
| R.E.A.L. | Revised European American Classification of Lymphoid Neoplasms |
|---|
| haematologic neoplasms | Neoplasms located in the blood and blood-forming tissue (the bone marrow and lymphatic tissue). The commonest forms are the various types of leukaemia, of lymphoma, and of the progressive, life-threatening forms of the myelodysplastic syndromes. (12 Dec 1998) |
|---|
| haematologic agents | Drugs that act on blood and blood-forming organs and those that affect the haemostatic system. (12 Dec 1998) |
|---|---|
| haematologic, gastrointestinal, and renal agents | A collective grouping for agents that act on the haematopoietic, gastrointestinal, and renal systems. (12 Dec 1998) |
| haematologic tests | Tests used in the analysis of the hemic system. (12 Dec 1998) |
| pregnancy complications, haematologic | The co-occurrence of pregnancy and a blood disease. The haematologic disorder may be of the cells or coagulation elements of the blood but does not refer to deficiencies or excesses of various substances in the blood, such as hypercalcaemia or hypocalcaemia. It may precede or follow conception and it may or may not have a deleterious effect on the pregnant woman or foetus. (12 Dec 1998) |
| bladder neoplasms | Cancers or tumours of the bladder. The majority of bladder neoplasms are of the transitional cell variety and are usually papillary and multicentric. (12 Dec 1998) |
| bone marrow neoplasms | Neoplasms located in the bone marrow. They are differentiated from neoplasms composed of bone marrow cells, such as myeloma. most bone marrow neoplasms are metastatic. (12 Dec 1998) |
| breast neoplasms, male | Any neoplasms of the male breast. These occur infrequently in males in developed countries, the incidence being about 1% of that in females. Two-thirds of patients present with intraductal carcinoma. The average age of onset is 60 years for men. Orchiectomy was the standard treatment but it has been replaced by tamoxifen as the initial therapy since oestrogen-receptor-positive tumours are predominant in males. Orchiectomy and mastectomy may be used if initial drug therapy is not successful. The prognosis is worse than that for females. (12 Dec 1998) |
| vascular neoplasms | <oncology> Neoplasms located in vascular tissue or specific veins. They are differentiated from neoplasms, vascular tissue which are neoplasms composed of vascular tissue, such as angiofibroma or haemangioma. (12 Dec 1998) |
| pancreatic cystic neoplasms | <radiology> Microcystic adenoma, glycogen, benign, mucinous cystic neoplasm, macrocystic adenoma, cystadenoma/cystadenocarcinoma, mucin, pre-malignant, Both occur more commonly in women, peak in middle age (12 Dec 1998) |
| pancreatic neoplasms | <radiology> Adenocarcinoma, most common, usually in pancreatic head, nasty (1-2% survival at 1 yr!), cystic neoplasms, slow-growing, more common in women, isleT-cell tumours, soft-tissue tumours (rare), metastases (breast, lung, melanoma, stomach, colon) (12 Dec 1998) |
| mammary neoplasms | Tumours of the mammary gland. Their occurrence is uncommon with the exception of the female dog, in which they account for 25% of all neoplasms. (12 Dec 1998) |
| paranasal sinus neoplasms | Neoplasms or tumours of the paranasal sinuses. Malignant neoplasms are rare, comprising 3% of all head and neck neoplasms. The majority arise in the maxillary sinus with malignancies of the ethmoid sinus constituting virtually all the remaining tumours. (12 Dec 1998) |
| genital neoplasms, male | Neoplasms of the male genitalia. (12 Dec 1998) |
| maxillary neoplasms | Cancer or tumours of the maxilla or upper jaw. (12 Dec 1998) |
| maxillary sinus neoplasms | Neoplasms or tumours of the maxillary sinus. The majority of paranasal sinus neoplasms arise here. They develop silently when confined to the sinus and produce symptoms on extension through the walls. (12 Dec 1998) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|